|
FAM190A expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62458935193399E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62458935193399E-12 |
| Normal-vs-Stage2 |
1.62481139653892E-12 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
1.62447832963153E-12 |
| Stage1-vs-Stage2 |
8.490400E-01 |
| Stage1-vs-Stage3 |
7.609800E-01 |
| Stage1-vs-Stage4 |
8.443000E-01 |
| Stage2-vs-Stage3 |
6.837600E-01 |
| Stage2-vs-Stage4 |
7.341200E-01 |
| Stage3-vs-Stage4 |
9.430800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.11022302462516E-16 |
| Normal-vs-AfricanAmerican |
3.94129173741931E-14 |
| Normal-vs-Asian |
<1E-12 |
| Caucasian-vs-AfricanAmerican |
7.065200E-01 |
| Caucasian-vs-Asian |
1.454120E-02 |
| AfricanAmerican-vs-Asian |
4.928100E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62447832963153E-12 |
| Normal-vs-Female |
1.62470037423645E-12 |
| Male-vs-Female |
7.322300E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62458935193399E-12 |
| Normal-vs-Age(41-60Yrs) |
1.62458935193399E-12 |
| Normal-vs-Age(61-80Yrs) |
8.88178419700125E-16 |
| Normal-vs-Age(81-100Yrs) |
6.4263999999925E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.714200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.503180E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.030400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.704570E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.355800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.869600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.865600E-02 |
| Classical-VS-Follicular |
2.660200E-02 |
| Classical-VS-Other |
7.620000E-02 |
| Classical-VS-Normal |
1.62470037423645E-12 |
| Tall-VS-Follicular |
6.382600E-04 |
| Tall-VS-Other |
6.591200E-01 |
| Tall-VS-Normal |
<1E-12 |
| Follicular-VS-Other |
5.116200E-03 |
| Follicular-VS-Normal |
1.68487446217114E-12 |
| Other-VS-Normal |
1.63946634046397E-12 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.62470037423645E-12 |
| Normal-vs-N1 |
<1E-12 |
| N0-vs-N1 |
3.424600E-01 |
|
|
